Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Magic Formula for Affymetrix
Motley Fool
Monday, August 22, 2011 - 1:04pm
tags:
Affymetrix
Biotech Stocks Pains Continue As Outflows Persist
Forbes
Monday, August 22, 2011 - 11:59am
tags:
Biomarin, Regeneron, Spectrum
Amgen: FDA to decide on possible new use for bone drug Xgeva by April 26
Yahoo/AP
Monday, August 22, 2011 - 11:58am
tags:
Amgen, Xgeva, FDA, prostate cancer
Kinetic Concepts Said to Get ConvaTec Bid Topping Apax’s $5 Billion Offer
Bloomberg
Monday, August 22, 2011 - 11:57am
tags:
Kinetic Concepts, ConvaTec, Apax, M&A, wound care
U.S. officials, docs step into drug-shortage fray
Fierce Pharma
Monday, August 22, 2011 - 11:55am
tags:
drug shortages
Zalicus May Have Long-Term Value, But What's Behind Exalgo's Weakness?
Seeking Alpha
Monday, August 22, 2011 - 11:54am
tags:
Zalicus, Exalgo, Covidien, opiods
Gilead's HIV Drug Quad: Close But No Cigar, Yet
Seeking Alpha
Monday, August 22, 2011 - 11:51am
tags:
HIV, Quad, Gilead
Vertex Pharma receives Canadian OK for Incivek
Yahoo/AP
Monday, August 22, 2011 - 11:50am
tags:
Vertex Pharmaceuticals, Canada, Incivek, hepatitis C
Ahead of the Bell: Seattle Genetics shares jump
Yahoo/AP
Monday, August 22, 2011 - 11:49am
tags:
Seattle Genetics, FDA, Adcetris, anaplastic large-cell lymphoma
Exelixis: Still Promising, Still Controversial
Seeking Alpha
Monday, August 22, 2011 - 11:47am
tags:
Exelixis, cabozantinib, Bone metastases
Data may prove Bristol, Pfizer drug a winner
Yahoo/Reuters
Monday, August 22, 2011 - 11:40am
tags:
Pfizer, stroke, Bristol-Myers Squibb, bloodthinners, Eliquis, Apixaban
5 Healthcare Dividend Stocks for 2011
Seeking Alpha
Monday, August 22, 2011 - 11:39am
tags:
Abbott Laboratories, Eli Lilly, dividends, Merck, Pfizer, Sanofi
Roche Rises After Good-Cholesterol Drug Shows Promise in Study
Bloomberg
Monday, August 22, 2011 - 10:33am
tags:
Roche, dalcetrapib
Pfizer's Animal Health Unit Is Best in Show
Yahoo/Morningstar
Monday, August 22, 2011 - 10:31am
tags:
Pfizer, animal health, Bayer AG, Merck, Eli Lilly
AEterna Zentaris: The Very Best Biotech Under $2
Seeking Alpha
Monday, August 22, 2011 - 10:30am
tags:
Aeterna Zentaris
A Healthy Forecast for Pharma
WSJ
Sunday, August 21, 2011 - 7:58pm
tags:
Needham: Teva remains top dog in generics pricing
Globes, Israel
Sunday, August 21, 2011 - 7:57pm
tags:
Teva Pharmaceuticals, generics
As Big Pharma downsizes, a major loss of brain power
Philadelphia Inquirer, PA
Sunday, August 21, 2011 - 7:56pm
tags:
Elder Pharma to launch 12 new products
Express India, India
Sunday, August 21, 2011 - 7:52pm
tags:
Elder Pharmaceuticals
Pharmaceutical firm's lawyer taped trying to foil lawsuit
Amarillo Globe-News, TX
Sunday, August 21, 2011 - 7:37pm
tags:
Baxter International, legal

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.